tirzepatide molecule File:Tirzepatide structure.svg Tirzepatide cuts heart failure risk

4.1.2 Clinical applications and implications This meta-analysis brings to light various clinically relevant aspects that must be considered from a public health perspective: Reassurance in Clinical Decision-Making As part of our results, it is evident that GLP-1 RAs do not increase the risk for gastrointestinal cancers and may even have protective effects for colorectal and liver cancers

GLP-1 drugs such as semaglutide and tirzepatide are at the center of a weight-loss drug revolution

Anthraquinones, flavonoids and phenylpropanoids can serve as competitive inhibitors of TYR due chemical structures similar to those of L-tyrosine or L-DOPA (76,77)

To support this metabolic process, some clinicians recommend co-supplementation with a methyl donor such as trimethylglycine (TMG) while on NAD+ injections

For the GIP receptor entity overview including the historical receptor-biology context, see GIP Receptor Explained